Pulmonary hypertension (PH) affects roughly 2–3 % of community‐dwelling adults and becomes more common with age.
Researchers at Rutgers University are recruiting 10,000 participants for a study exploring the role of genetic differences, called variants, on the risk of pulmonary hypertension. We have teamed up with the company Regeneron Pharmaceuticals to launch a large study of the genetics of pulmonary hypertension that is easy to participate in. No office visit is required. Instead, there’s an easily accessible set of questions to answer (that will take about 15 minutes), combined with returning a “spit kit” that will be mailed to participants. Participants will not be compensated, but may opt to receive a report about their genetic ancestry at no cost. Participants may opt to fill in additional surveys, and participants may opt to make parts of their electronic medical records available to enhance the study’s data.
We are looking for both women and men, and people who have had pulmonary hypertension and people who have not.
Findings from this study may lead to improved and personalized diagnostics and treatment.
Our study enrollment portal is under development, check back soon to join the study.
Click here for Pulmonary Hypertension Study Frequently Asked Questions (F.A.Q.)